IDEAYA Biosciences closes $46 mln Series A, adds to leadership team
IDEAYA Biosciences, Inc. raised $46 million in Series A financing from 5AM Ventures, Canaan Partners, Celgene, WuXi Healthcare Ventures, Novartis Institute of Biomedical Research and Alexandria Real Estate. IDEAYA is a biotechnology company pursuing small-molecule research in synthetic lethality and immuno-oncology.
4 May 2016•3 mins read
